Stock AREC ARECOR THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Market Closed - London S.E.
Other stock markets
 16:35:05 26/04/2024 BST 		5-day change 1st Jan Change
136.5 GBX 0.00% Intraday chart for Arecor Therapeutics plc +6.23% -25.21%
04-23 Arecor chief financial officer to leave in July after five years AN
04-23 Arecor Therapeutics CFO to Leave in July MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arecor chief financial officer to leave in July after five years
Arecor Therapeutics plc Announces Stepping Down of Susan Lowther as Company Secretary and as A Board Director, Effective from July 22,2024
Arecor to develop "holy grail" diabetes treatment with partner TRx
Arecor Therapeutics plc and Trx Biosciences Limited Announces Research Collaboration for the Formulation Development of an Oral GLP-1 Receptor Agonist Product
EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV
Arecor Therapeutics hails Arestat as 2023 performance "strong"
Arecor pleased as investee Inhibrx sells therapy to Sanofi
Patent boosts for DG Innovate and Arecor Therapeutics
Arecor expands speciality hospital collaboration with partner
Arecor Therapeutics Expands Formulation Study Collaboration with Pharmaceutical Partner
Arecor Therapeutics plc Expands Ongoing, Exclusive Formulation Study Collaboration with the Pharmaceutical Division of One of the World's Largest Chemicals Marketing and Pharmaceuticals Companies
Arecor inks co-development deal with global medical company
Arecor Therapeutics Signs Exclusive License Option Agreement for Oncology Product
Arecor Therapeutics plc Announces Co-Development and Exclusive Licence Option Agreement
Arecor inks Eli Lilly deal; RBG appoints McNair CFO
Arecor Therapeutics plc Signs Further Collaboration Agreement with Lilly and Company
Arecor Therapeutics gets "milestone payment" from AT220 sale
Arecor Therapeutics to Receive Milestone Payment from Maiden Commercial Sale of Arestat Technology Product
Troy Income suspends buyback of shares
Arecor Therapeutics ups subject numbers for insulin-focused trial
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AREC Stock
  4. News Arecor Therapeutics plc
  5. Other languages